Form 8-K - Current report:
SEC Accession No. 0001213900-24-106222
Filing Date
2024-12-06
Accepted
2024-12-06 08:31:00
Documents
15
Period of Report
2024-12-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea022382202-8k_synergy.htm   iXBRL 8-K 28545
2 PRESS RELEASE, DATED DECEMBER 6, 2024 ea022382202ex99-1_synergy.htm EX-99.1 96785
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2927
  Complete submission text file 0001213900-24-106222.txt   313478

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snyr-20241206.xsd EX-101.SCH 3021
5 XBRL LABEL FILE snyr-20241206_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE snyr-20241206_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea022382202-8k_synergy_htm.xml XML 3528
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 241530590
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)